secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 77118 grounded facts newest October 13, 2026, 5:25 PM ET RSS · JSON

Showing 1151–1200 of 33813

Departed

Donald Poulton

Chief Executive Officer
MFIN · MEDALLION FINANCIAL CORP
Effective
2026-06-30
Successor
David Justin Haley
Filed
June 12, 2026, 8:30 AM ET
On June 11, 2026, Mr. Donald Poulton notified Medallion Financial Corp. and Medallion Bank of his intention to retire from his position as Chief Executive Officer of Medallion Bank, effective June 30, 2026.
Departed

Jason Pernell

President
TCNNF · Trulieve Cannabis Corp.
Effective
2026-06-11
Filed
June 12, 2026, 8:12 AM ET
On June 11, 2026 (the “Termination Date”), the Company and Jason Pernell mutually agreed that Mr. Pernell shall terminate his employment his position of President of Trulieve Cannabis Corp. (the “Company”) effective immediately.
Departed

Michael Amoroso

Director
ABEO · ABEONA THERAPEUTICS INC.
Effective
2026-06-11
Filed
June 12, 2026, 7:30 AM ET
On June 11, 2026, Michael Amoroso resigned as a member of the Board of Directors (the “Board”) of Abeona Therapeutics Inc. (the “Company”) effective immediately.
Departed

William Conkling

Executive Vice President and Chief Financial Officer
INN · Summit Hotel Properties, Inc.
Effective
2026-06-15
Successor
Jonathan Stanner
Filed
June 12, 2026, 6:36 AM ET
On June 12, 2026, Summit Hotel Properties, Inc. (the “Company”) announced that William Conkling, the Company’s Executive Vice President and Chief Financial Officer, has resigned as an officer and employee of the Company effective as of June 15, 2026
Departed (interim)

Bryan D. Coy

Executive Vice President and Chief Financial Officer
CNNE · Cannae Holdings, Inc.
Effective
2026-06-10
Successor
Brett A. Correia
Filed
June 11, 2026, 6:25 PM ET
On June 10, 2026, Bryan D. Coy resigned from his position as Executive Vice President and Chief Financial Officer of Cannae Holdings, Inc.
Departed

Daniel M. McCabe

member of the Board of Directors
GLND · Greenland Energy Co
Effective
2026-06-05
Successor
Carol Craig
Filed
June 11, 2026, 5:20 PM ET
On June 5, 2026, Daniel M. McCabe notified Greenland Energy Company, a Texas corporation (the “Company”), of his resignation from his position as a member of the Board of Directors (the “Board”) of the Company, effective immediately.
Departed

Viktor Balan

President, Secretary, Treasurer, Chief Executive Officer, and a member of the Board of Directors
STWI · StageWise Strategies Corp.
Effective
2026-06-05
Filed
June 11, 2026, 5:15 PM ET
Viktor Balan resigned from his positions as President, Secretary, Treasurer, Chief Executive Officer and a member of the Board of Directors of the Company (the “Board”), and Alarcon Martinez Marcelo Ramon and Anna Toczko each resigned as a member of the Board, each effective as of June 5, 2026.
Departed

Alarcon Martinez Marcelo Ramon

member of the Board of Directors
STWI · StageWise Strategies Corp.
Effective
2026-06-05
Filed
June 11, 2026, 5:15 PM ET
and Alarcon Martinez Marcelo Ramon and Anna Toczko each resigned as a member of the Board, each effective as of June 5, 2026.
Departed

Anna Toczko

member of the Board of Directors
STWI · StageWise Strategies Corp.
Effective
2026-06-05
Filed
June 11, 2026, 5:15 PM ET
and Alarcon Martinez Marcelo Ramon and Anna Toczko each resigned as a member of the Board, each effective as of June 5, 2026.
Departed

Irwin Katsof

Director
IDT · IDT CORP
Effective
2026-06-09
Successor
William Conkling
Filed
June 11, 2026, 5:03 PM ET
On June 9 2026, Irwin Katsof notified IDT Corporation (the “Company”) of his resignation from the board of directors of the Company (the “Board”) and the respective committees of the Board on which he served.
Departed

E. Ted Botner

Executive Vice President, General Counsel and Corporate Secretary
MUR · MURPHY OIL CORP
Effective
2026-06-11
Successor
Roger W. Landes
Filed
June 11, 2026, 4:47 PM ET
E. Ted Botner, Executive Vice President, General Counsel and Corporate Secretary, will retire from his position as Executive Vice President, General Counsel and Corporate Secretary, effective immediately, and will retire from the Company on June 30, 2026.
Departed

William Fairey

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Patrick Treanor

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Brian J. G. Pereira, MD

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Bethany Sensenig

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Edward W. Unkart

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Laurence Reid, PhD

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Benjamin L. Palleiko

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Nancy Stuart

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Daniel Durn

member of our board of directors and Chair of the Audit Committee
MRVL · Marvell Technology, Inc.
Effective
2026-06-10
Filed
June 11, 2026, 4:33 PM ET
On June 10, 2026, Daniel Durn, a member of our board of directors (the "Board") and Chair of the Audit Committee, resigned from the Board, including from all committees of the Board on which he served, effective immediately, and was subsequently appointed by the Board to serve as the Company’s Chief Financial Officer and Executive Vice President and principal financial officer, effective June 15, 2026.
Departed

Willem Meintjes

Chief Financial Officer and Executive Vice President
MRVL · Marvell Technology, Inc.
Effective
2026-06-15
Successor
Daniel Durn
Filed
June 11, 2026, 4:33 PM ET
On June 11, 2026, Marvell Technology, Inc. (the "Company") announced that Willem Meintjes, the Company’s Chief Financial Officer and Executive Vice President, notified the Company on June 10, 2026 of his decision to resign from his position effective as of June 15, 2026.
Departed

Greg Tourangeau

Vice President, Finance and principal accounting officer
FULC · Fulcrum Therapeutics, Inc.
Filed
June 11, 2026, 4:30 PM ET
On June 10, 2026, Fulcrum and Greg Tourangeau, Fulcrum’s Vice President, Finance and principal accounting officer, mutually agreed that Mr. Tourangeau will depart from his position at Fulcrum on a date to be agreed between Mr. Tourangeau and Fulcrum.
Departed

Philip R. Martens

Chairman of the Board
GPK · GRAPHIC PACKAGING HOLDING CO
Effective
2026-06-11
Successor
Larry M. Venturelli
Filed
June 11, 2026, 4:30 PM ET
Effective June 11, 2026, following the Annual Meeting of Stockholders, Mr. Philip R. Martens retired from his positions as a member and Chairman of the Board of Directors (the “Board”) of Graphic Packaging Holding Company (the “Company”).
Departed

Jeffrey S. Lorberbaum

Chief Executive Officer
MHK · MOHAWK INDUSTRIES INC
Effective
2026-09-30
Successor
Paul F. De Cock
Filed
June 11, 2026, 4:16 PM ET
Mr. De Cock will succeed Jeffrey S. Lorberbaum, who will retire from his role as CEO of the Company at that time
Departed

Tatiana Segal

director of the Delegated Sponsor
MSBT · Morgan Stanley Bitcoin Trust
Effective
2026-05-07
Filed
June 11, 2026, 4:15 PM ET
Tatiana Segal notified the Delegated Sponsor of her intention to resign from her position as a director of the Delegated Sponsor effective May 7, 2026.
Departed

Ruairi O'Healai

director of the Delegated Sponsor
MSBT · Morgan Stanley Bitcoin Trust
Effective
2026-06-05
Filed
June 11, 2026, 4:15 PM ET
Ruairi O’Healai notified Morgan Stanley Investment Management Inc., the delegated sponsor of Morgan Stanley Bitcoin Trust (the “Delegated Sponsor”), of his intention to resign from his position as a director of the Delegated Sponsor effective June 5, 2026.
Departed

Ranjeev Krishana

Director
ONC · BeOne Medicines Ltd.
Effective
2026-06-11
Filed
June 11, 2026, 4:13 PM ET
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Departed

Qingqing Yi

Director
ONC · BeOne Medicines Ltd.
Effective
2026-06-11
Filed
June 11, 2026, 4:13 PM ET
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Departed

Corazon (Corsee) D. Sanders

Director
ONC · BeOne Medicines Ltd.
Effective
2026-06-11
Filed
June 11, 2026, 4:13 PM ET
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Departed

Michael Goller

Director
ONC · BeOne Medicines Ltd.
Effective
2026-06-11
Filed
June 11, 2026, 4:13 PM ET
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Departed

Daniel Durn

Chief Financial Officer and Executive Vice President, Finance, Technology, Security and Operations
ADBE · ADOBE INC.
Effective
2026-06-15
Successor
Steven Day
Filed
June 11, 2026, 4:08 PM ET
On June 8, 2026, Daniel Durn notified the Company of his decision to resign as Chief Financial Officer and Executive Vice President, Finance, Technology, Security and Operations, effective June 15, 2026.
Departed

Eric Kash

Executive Vice President and Director
CJMB · CALLAN JMB INC.
Effective
2026-06-05
Filed
June 11, 2026, 4:01 PM ET
On June 5, 2026, Eric Kash resigned from his position as Executive Vice President of Callan JMB Inc. (the “Company”), and from his position as a member of the Board of Directors of the Company, including any committee positions, effective as of June 5, 2026.
Departed

Russell R. Shaller

President and Chief Executive Officer
BRC · BRADY CORP
Effective
2026-06-08
Successor
Vineet Nargolwala
Filed
June 11, 2026, 3:01 PM ET
On June 8, 2026, Brady Corporation (the “Company”) announced that Russell R. Shaller will be retiring as the Company’s President and Chief Executive Officer, effective June 8, 2026 (the “Effective Date”).
Departed

Christodoulos Tzoutzakis

Chief Operating Officer and Chief Technology Officer
ELVG · Elvictor Group, Inc.
Effective
2026-06-11
Filed
June 11, 2026, 2:23 PM ET
Effective June 11, 2026, the Board of Directors (the “Board”) of Elvictor Group, Inc. (the “Company”) removed without cause Christodoulos Tzoutzakis as the Company’s Chief Operating Officer and Chief Technology Officer.
Departed

Kenneth W. Perry

Chief Financial Officer
RGPX · REGENEREX PHARMA, INC.
Filed
June 11, 2026, 1:52 PM ET
As of June 5, 2026, the Company has commenced legal proceedings against its former Chief Financial Officer, Kenneth W. Perry (the "Former CFO"), in the matter of Regenerex Pharma, Inc. v. Kenneth W. Perry , Smith County Chancery Court, Case No. 2026-CV-8813.
Departed

Tony Goodman

Class I Director
ADIL · ADIAL PHARMACEUTICALS, INC.
Effective
2026-06-11
Successor
Matt Davidson
Filed
June 11, 2026, 12:43 PM ET
In connection with the Merger, effective as of the First Effective Time, Tony Goodman resigned as a Class I Director of the Company.
Departed

Michael P. Gallagher

Senior Vice President – Chief Accounting Officer
CPT · CAMDEN PROPERTY TRUST
Effective
2026-07-02
Successor
Kevin J. Necas, Jr.
Filed
June 11, 2026, 11:16 AM ET
Michael P. Gallagher, Senior Vice President – Chief Accounting Officer of Camden Property Trust (the “Company”), who is designated as the Company’s principal accounting officer, informed the Company he will be retiring from the Company effective July 2, 2026.
Departed

Wei Zurui

Chief Financial Officer and Director
LVPA · LVPAI GROUP Ltd
Effective
2026-06-09
Successor
Zhang Wenmin
Filed
June 11, 2026, 10:26 AM ET
On June 9, 2026, Wei Zurui ceased to serve as Chief Financial Officer and a member of the Board of Directors of the Company.
Departed

Chen Yuanhang

Chief Executive Officer
LVPA · LVPAI GROUP Ltd
Effective
2026-06-09
Successor
Zhao Ling
Filed
June 11, 2026, 10:26 AM ET
On June 9, 2026, Chen Yuanhang ceased to serve as Chief Executive Officer of LVPAI GROUP LIMITED
Departed

Christopher Marrs

President and Chief Executive Officer
WAMFF · Alaska Silver Corp.
Effective
2026-10-01
Successor
Aaron Schutt
Filed
June 11, 2026, 8:44 AM ET
Christopher Marrs would cease serving as President and Chief Executive Officer of the Company as of October 1, 2026.
Departed

Elias J. Sabo

Chief Executive Officer and Director
CODI · Compass Diversified Holdings
Effective
2026-12-31
Successor
Zach Sawtelle
Filed
June 11, 2026, 6:31 AM ET
On June 8, 2026, Elias J. Sabo informed Compass Group Diversified Holdings LLC (the “Company”) and Compass Diversified Holdings (NYSE: CODI) (the “Trust” and, together with the Company, “CODI”), as well as Compass Group Management LLC (“CGM”) and Sostratus LLC (“Sostratus”), of his decision to retire from his position as the Chief Executive Officer and a director of the Company and as a regular trustee of the Trust, each effective December 31, 2026.
Departed

Patricia Kaelin

Chief Financial Officer
OLOX · OLENOX INDUSTRIES INC.
Effective
2026-06-05
Filed
June 10, 2026, 9:15 PM ET
On June 5, 2026, Olenox Industries, Inc. (the “Company”) informed Patricia Kaelin, Chief Financial Officer of the Company, of her dismissal from the Company, and the Company received a resignation letter back from her the same day.
Departed

Parker White

Chief Operating Officer and Chief Investment Officer
DFDV · DeFi Development Corp.
Effective
2026-06-08
Filed
June 10, 2026, 5:27 PM ET
On June 8, 2026, Parker White, Chief Operating Officer and Chief Investment Officer of DeFi Development Corp. (the "Company"), resigned from his positions with the Company and the Company agreed to a separation agreement (the "Separation Agreement") with respect to the termination of Mr. White’s employment with the Company, effective as of June 8, 2026.
Departed

Henry Yeagley

Director
EQPT · EquipmentShare.com Inc
Effective
2026-06-05
Successor
Damian Giangiacomo
Filed
June 10, 2026, 5:26 PM ET
On June 5, 2026, Henry Yeagley and John Weinstein each resigned from the Board, effective as of such date.
Departed

John Weinstein

Director
EQPT · EquipmentShare.com Inc
Effective
2026-06-05
Successor
Harley Miller
Filed
June 10, 2026, 5:26 PM ET
On June 5, 2026, Henry Yeagley and John Weinstein each resigned from the Board, effective as of such date.
Departed

Michael A. Pollner

Senior Vice President, General Counsel & Secretary
JJSF · J&J SNACK FOODS CORP
Effective
2026-06-30
Filed
June 10, 2026, 5:00 PM ET
On June 4, 2026, Michael A. Pollner, Senior Vice President, General Counsel & Secretary of J & J Snack Foods Corp. (the “Company”), provided a notice of resignation to the Company, effective June 30, 2026.
Departed

Jay D. Martin

Chief Financial Officer
CACC · CREDIT ACCEPTANCE CORP
Effective
2026-07-27
Successor
Joseph Billante
Filed
June 10, 2026, 4:40 PM ET
On June 5, 2026, Jay D. Martin, Chief Financial Officer of Credit Acceptance Corporation (referred to as the “Company,” “Credit Acceptance,” “we,” “our” or “us”) and, as such, the Company’s principal financial officer and principal accounting officer, informed the Company that he has decided to retire as an officer and employee of the Company effective July 27, 2026.
Departed

Cheddi Rai

officer, director, employee, consultant, or other positions
VISM · VISIUM TECHNOLOGIES, INC.
Effective
2026-06-08
Filed
June 10, 2026, 4:29 PM ET
Effective upon execution of the Release Agreement on June 8, 2026, Cheddi Rai resigned from any and all officer, director, employee, consultant, or other positions with Visium Technologies, Inc. and its subsidiaries and affiliates.
Departed

Anna Eramo

Chief Medical Officer
LBRX · LB PHARMACEUTICALS INC
Effective
2026-06-15
Filed
June 10, 2026, 4:16 PM ET
On June 8, 2026, she resigned from her position as Chief Medical Officer of the Company effective June 15, 2026 (the " Separation Date ").
Departed

Rachel Labrecque

principal accounting officer
APLE · Apple Hospitality REIT, Inc.
Effective
2026-06-09
Successor
Elizabeth S. Perkins
Filed
June 10, 2026, 4:15 PM ET
Ms. Labrecque passed away on June 9, 2026.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.